Location History:
- Les Ulis, FR (2003 - 2011)
- Les Ullis, FR (2011)
- Paris, FR (2010 - 2015)
Company Filing History:
11 out of 377 
2 out of 207 
1 out of 1,827 
Years Active: 2003-2015
Title: **Gilles Doerflinger: Innovator in Pharmaceutical Chemistry**
Introduction
Gilles Doerflinger, based in Les Ulis, France, is a distinguished inventor known for his contributions to pharmaceutical chemistry. With a portfolio of 16 patents, his work primarily focuses on the development of innovative chemical compounds with therapeutic applications. His inventions aim to advance the field of medicine, particularly in the area of cancer treatment.
Latest Patents
Doerflinger's latest patents include significant advancements in the realm of pyrimidine and pyrazolyl derivatives. One of his notable inventions is titled "Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as AKT (PKB) phosphorylation inhibitors." This invention details a novel method for synthesizing chemical compounds derived from pyrimidines, which have therapeutic potential as drugs and comprise pharmaceutical compositions containing these active ingredients.
Another groundbreaking patent is focused on "Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them." This patent presents novel derivatives characterized by complex molecular structures that may possess essential medicinal properties. The chemical compositions and their therapeutic potential hold promise for future clinical applications.
Career Highlights
Gilles Doerflinger has worked in leading pharmaceutical companies, including Aventis Pharma S.A. and Aventis Pharmaceuticals Inc. These roles have allowed him to leverage his expertise in medicinal chemistry and innovation to contribute to the development of new therapies. His work has positioned him as a prominent figure in the pharmaceutical arena, impacting how diseases are treated.
Collaborations
Throughout his career, Doerflinger has collaborated with esteemed colleagues, including Jean-Christophe Carry and Gilles Dutruc-Rosset. These partnerships underscore the importance of teamwork and knowledge exchange in advancing scientific research and achieving breakthroughs in drug development.
Conclusion
Gilles Doerflinger is a notable inventor whose work has substantially contributed to the field of pharmaceutical chemistry. With a robust portfolio of patents, he continues to innovate and push the boundaries of drug development. His significant contributions serve as a foundation for future advancements in medical therapies, particularly in combating diseases such as cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.